Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Jul-24 5:20 PM View:  | Pyszczymuka Greg Chief Commercial Officer | Aytu Biopharma, Inc (AYTU) | 30-Jun-24 | Option Exercise | 208 | -- | -- | < 1% 22.77K to 22.98K | |
| 02-Apr-24 4:44 PM View: | Pyszczymuka Greg Chief Commercial Officer | Aytu Biopharma, Inc (AYTU) | 31-Mar-24 | Option Exercise | 208 | -- | -- | < 1% 22.56K to 22.77K | |
| 02-Jan-24 4:37 PM View: | Pyszczymuka Greg Chief Commercial Officer | Aytu Biopharma, Inc (AYTU) | 31-Dec-23 | Option Exercise | 209 | -- | -- | < 1% 22.35K to 22.56K | |
| 03-Oct-23 4:37 PM View: | Pyszczymuka Greg Chief Commercial Officer | Aytu Biopharma, Inc (AYTU) | 30-Sep-23 | Option Exercise | 208 | -- | -- | < 1% 22.14K to 22.35K | |
| 18-Aug-23 6:27 PM View: | Jain Abhinav Director | Aytu Biopharma, Inc (AYTU) | 16-Aug-23 | Grant | 6,500 | -- | -- | 433% 1.5K to 8.0K | |
| 15-Aug-23 7:38 PM View: | Dockery Carl Director | Aytu Biopharma, Inc (AYTU) | 11-Aug-23 | Grant | 1,500 | -- | -- | 20% 7.44K to 8.94K | |
| 15-Aug-23 7:49 PM View: | Jain Abhinav Director | Aytu Biopharma, Inc (AYTU) | 11-Aug-23 | Grant | 1,500 | -- | -- | 100% 0 to 1.5K | |
| 15-Aug-23 7:39 PM View: | Donofrio John Jr. Director | Aytu Biopharma, Inc (AYTU) | 11-Aug-23 | Grant | 1,500 | -- | -- | 197% 0.76K to 2.26K | |
| 15-Aug-23 7:44 PM View: | Liu Vivian H Director | Aytu Biopharma, Inc (AYTU) | 11-Aug-23 | Grant | 1,500 | -- | -- | 440% 0.34K to 1.84K | |
| 06-Jul-23 3:26 PM View: | Pyszczymuka Greg Chief Commerical Officer | Aytu Biopharma, Inc (AYTU) | 30-Jun-23 | Option Exercise | 208 | -- | -- | < 1% 21.93K to 22.14K | |
| 20-Jun-23 8:35 AM View: | Pyszczymuka Greg Chief Commerical Officer | Aytu Biopharma, Inc (AYTU) | 16-Jun-23 | Purchase | 12,000 | $1.87 | $22,428.00 | 121% 9.94K to 21.93K | |
| 15-Jun-23 1:52 PM View: | Disbrow Joshua R. Chief Executive Officer Director | Aytu Biopharma, Inc (AYTU) | 14-Jun-23 | Purchase | 14,000 | $1.86 | $26,079.20 | 24% 57.59K to 71.59K | |
| 20-Jun-23 8:29 AM View: | Pyszczymuka Greg Chief Commerical Officer | Aytu Biopharma, Inc (AYTU) | 25-Apr-23 | Option Exercise | 833 | -- | -- | 9% 9.1K to 9.94K | |
| 10-Feb-23 6:13 PM View: | Liu Vivian H Director | Aytu Biopharma, Inc (AYTU) | 08-Feb-23 | Grant | 6,500 | -- | -- | 2000% 0.33K to 6.83K | |
| 23-Dec-22 5:13 PM View: | Dockery Carl Director | Aytu Biopharma, Inc (AYTU) | 21-Dec-22 | Disposition | 40,000 | -- | -- | (21%) 188.81K to 148.81K | |
| 23-Dec-22 5:31 PM View: | Cantrell Gary Director | Aytu Biopharma, Inc (AYTU) | 21-Dec-22 | Disposition | 40,000 | -- | -- | (20%) 204.09K to 164.09K | |
| 23-Dec-22 5:40 PM View: | Donofrio John Jr. Director | Aytu Biopharma, Inc (AYTU) | 21-Dec-22 | Disposition | 187,804 | -- | -- | (92%) 203.07K to 15.27K | |
| 23-Dec-22 5:27 PM View: | Disbrow Joshua R. Chief Executive Officer Director | Aytu Biopharma, Inc (AYTU) | 20-Dec-22 | Disposition | 80,000 | -- | -- | (6%) 1.23M to 1.15M | |
| 21-Dec-22 9:17 AM View: | Disbrow Joshua R. Chief Executive Officer Director | Aytu Biopharma, Inc (AYTU) | 19-Dec-22 | Private Purchase | 112,371 | $0.22 | $25,047.50 | 10% 1.12M to 1.23M | |
| 21-Dec-22 9:15 AM View: | Pyszczymuka Greg Chief Commercial Officer | Aytu Biopharma, Inc (AYTU) | 19-Dec-22 | Private Purchase | 100,000 | $0.24 | $24,480.00 | 122% 82.06K to 182.06K | |
| 21-Nov-22 9:30 AM View: | Disbrow Joshua R. Chief Executive Officer Director | Aytu Biopharma, Inc (AYTU) | 18-Nov-22 | Grant | 222,000 | $0.24 | $52,614.00 | 25% 897.51K to 1.12M | |
| 21-Nov-22 9:30 AM View: | Oki Mark K Chief Financial Officer | Aytu Biopharma, Inc (AYTU) | 18-Nov-22 | Grant | 90,000 | $0.23 | $20,700.00 | 90% 100.0K to 190.0K | |
| 01-Jul-22 3:12 PM View: | Liu Vivian H Director | Aytu Biopharma, Inc (AYTU) | 01-Jul-22 | Grant | 6,500 | -- | -- | 100% 0 to 6.5K | |
| 19-Jan-22 11:42 AM View: | Oki Mark K Chief Financial Officer | Aytu Biopharma, Inc (AYTU) | 17-Jan-22 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 16-Apr-21 10:00 PM View: | Donofrio John Jr. Director | Aytu Biopharma, Inc (AYTU) | 16-Apr-21 | Grant | 187,804 | -- | -- | 1230% 15.27K to 203.07K | |
| 16-Apr-21 10:00 PM View: | MacAluso Michael Director | Aytu Biopharma, Inc (AYTU) | 16-Apr-21 | Grant | 187,804 | -- | -- | 926% 20.27K to 208.08K | |
| 16-Apr-21 10:00 PM View: | Dockery Carl Director | Aytu Biopharma, Inc (AYTU) | 16-Apr-21 | Grant | 187,804 | -- | -- | 18762% 1.0K to 188.81K | |
| 16-Apr-21 10:00 PM View: | Disbrow Joshua R. Chief Executive Officer Director | Aytu Biopharma, Inc (AYTU) | 16-Apr-21 | Grant | 800,000 | -- | -- | 820% 97.51K to 897.51K | |
| 16-Apr-21 10:00 PM View: | Cantrell Gary Director | Aytu Biopharma, Inc (AYTU) | 16-Apr-21 | Grant | 187,804 | -- | -- | 1153% 16.29K to 204.09K | |
| 12-Apr-21 3:22 PM View: | Hecht Beth Director | Aytu Biopharma, Inc (AYTU) | 08-Apr-21 | Grant | 6,500 | -- | -- | 255% 2.55K to 9.05K | |
| 12-Apr-21 4:39 PM View: | McLaughlin Gerald W. Director | Aytu Biopharma, Inc (AYTU) | 08-Apr-21 | Grant | 6,500 | -- | -- | 26% 24.9K to 31.4K | |
| 05-Apr-21 7:15 PM View: | Eisenstadt Richard I Chief Financial Officer | Aytu Biopharma, Inc (AYTU) | 31-Mar-21 | Grant | 55,000 | -- | -- | 400% 13.73K to 68.73K | |
| 10-May-21 9:25 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 29-Mar-21 | Acquisition (other) | -- | -- | -- | 0% 2.68M | |
| 10-May-21 9:25 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 29-Mar-21 | Acquisition (other) | 2,085 | -- | -- | < 1% 2.68M to 2.68M | |
| 10-May-21 9:25 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 20-Mar-21 | Acquisition (other) | 6,959 | -- | -- | < 1% 2.67M to 2.68M | |
| 10-May-21 9:25 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 20-Mar-21 | Acquisition (other) | -- | -- | -- | 0% 2.68M | |
| 15-Dec-20 7:17 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 11-Dec-20 | Purchase | -- | -- | -- | 0% 2.67M | |
| 15-Dec-20 7:17 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 11-Dec-20 | Market Purchase | 1,333,330 | $6.00 | $8,000,000.00 | 100% 1.33M to 2.67M | (100%) |
| 12-Jun-20 5:46 PM View: | Green David A Chief Financial Officer | Aytu Biopharma, Inc (AYTU) | 08-Jun-20 | Grant | 250,000 | -- | -- | 92% 271.25K to 521.25K | |
| 12-Jun-20 5:44 PM View: | Disbrow Joshua R. Chief Executive Officer Director | Aytu Biopharma, Inc (AYTU) | 08-Jun-20 | Grant | 450,000 | -- | -- | 86% 525.05K to 975.05K | |
| 12-Jun-20 5:42 PM View: | Cantrell Gary Director | Aytu Biopharma, Inc (AYTU) | 08-Jun-20 | Grant | 10,000 | -- | -- | 7% 152.84K to 162.84K | |
| 29-Apr-20 8:22 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 27-Apr-20 | Sale | -- | -- | -- | 0% -- | |
| 29-Apr-20 8:22 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 27-Apr-20 | Option Exercise | 5,000,000 | $1.25 | $6,250,000.00 | 4590% 108.92K to 5.11M | |
| 29-Apr-20 8:22 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 27-Apr-20 | Market Option Sale | 5,000,000 | $1.82 | $9,100,000.00 | (98%) 5.11M to 108.92K | (100%) |
| 29-Apr-20 8:22 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 27-Apr-20 | Option Exercise | -- | -- | -- | 0% 5.11M | |
| 29-Apr-20 8:22 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 27-Apr-20 | Market Sale | 108,921 | $1.82 | $198,236.00 | (100%) 108.92K to 0 | (100%) |
| 27-Apr-20 9:30 AM View: | Cerecor Inc. 10% Owner | Aytu Biopharma, Inc (AYTU) | 15-Apr-20 | Market Sale | 92,777 | $1.55 | $144,092.00 | (< 1%) 9.81M to 9.71M | (100%) |
| 27-Apr-20 9:30 AM View: | Cerecor Inc. 10% Owner | Aytu Biopharma, Inc (AYTU) | 10-Apr-20 | Conversion | 9,805,840 | -- | -- | 100% 0 to 9.81M | |
| 08-Apr-20 4:23 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 06-Apr-20 | Acquisition (other) | 108,920 | -- | -- | 100% 108.92K to 217.84K | |
| 08-Apr-20 4:23 PM View: | Armistice Capital, LLC Director | Aytu Biopharma, Inc (AYTU) | 06-Apr-20 | Acquisition (other) | -- | -- | -- | 0% 217.84K |
